Cargando…
Myocardial bridging is a potential risk factor of very late stent thrombosis of drug eluting stent
Drug eluting stents have been implanted worldwide and used in nearly 90% of percutaneous coronary interventions in China. Although many randomized trials have confirmed the efficacy and safety profile of drug eluting stents, they were not powered to detect or exclude the effect of drug eluting stent...
Autores principales: | Jiang, Qixia, Liang, Chun, Wu, Zonggui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3560621/ https://www.ncbi.nlm.nih.gov/pubmed/22534717 http://dx.doi.org/10.12659/MSM.882717 |
Ejemplares similares
-
Association of Localized Hypersensitivity and In-Stent Neoatherosclerosis with the Very Late Drug-Eluting Stent Thrombosis
por: Yamaji, Kyohei, et al.
Publicado: (2014) -
Pathologic Etiologies of Late and Very Late Stent Thrombosis following First-Generation Drug-Eluting Stent Placement
por: Otsuka, Fumiyuki, et al.
Publicado: (2012) -
Pathogenesis of late in-stent thrombosis after treatment with drug-eluting stents
por: Hao, Hiroyuki
Publicado: (2012) -
Very Late Stent Thrombosis in a Drug-Eluting Stent due to Interruption of Anti-Platelet Agents in Patients With Acute Myocardial Infarction and Thrombocytosis
por: Choi, Hong Sang, et al.
Publicado: (2011) -
Very Late Stent Thrombosis due to Neointimal Rupture After Paclitaxel-Eluting Stent Implantation
por: Kee, Won Ju, et al.
Publicado: (2011)